Richard L. Cassin Publisher and Editor
Andy Spalding Senior Editor
Jessica Tillipman Senior Editor
Elizabeth K. Spahn Contributing Editor
Eric Carlson Contributing Editor
Benjamin Kessler Contributing Editor
Michael Kuria Contributing Editor
Thomas Fox Contributing Editor
Philip Fitzgerald Contributing Editor
Marc Alain Bohn Contributing Editor
Michael Scher Contributing Editor
Bill Waite Contributing Editor
Shruti J. Shah Contributing Editor
Dr. Henry Wong Contributing Editor
Russell A. Stamets Contributing Editor
Mark R. Friedman Contributing Editor
Andrew Reichardt Editorial Intern
Richard L. Cassin | Thursday, February 28, 2013 at 1:38PM 
Following a five-year investigation into the overseas marketing and sales practices of medical device makers, the DOJ and SEC won't bring any FCPA enforcement against one of the targeted companies, Zimmer Holdings Inc.
Richard L. Cassin | Wednesday, February 13, 2013 at 8:08AM 
Five employees of orthopedic device maker DePuy are facing criminal charges in Greece for bribing doctors at government-owned hospitals.
Richard L. Cassin | Wednesday, November 7, 2012 at 12:28PM 
Medical device maker Zimmer Holdings, Inc. said in an SEC filing yesterday that it can't predict the outcome of DOJ and SEC investigations into its overseas sales practices.
Richard L. Cassin | Wednesday, June 20, 2012 at 3:51AM A letter from two Congressmen to the U.S. Chamber of Commerce said companies that had settled FCPA cases or were under investigation for foreign bribery had helped lead efforts to narrow the scope of the law.
Richard L. Cassin | Monday, March 26, 2012 at 12:08PM Biomet Inc. today became the latest medical device maker to settle FCPA offenses.
Richard L. Cassin | Wednesday, March 21, 2012 at 7:28AM Since we first listed the top ten FCPA disgorgements a year ago, two new companies joined the list -- Johnson & Johnson and Magyar Telekom. They replaced GE and Baker Hughes.
Richard L. Cassin | Monday, February 6, 2012 at 3:28PM U.K.-based medical device maker Smith & Nephew plc agreed to pay $22.2 million to settle Foreign Corrupt Practices Act offenses committed by its U.S. and German subsidiaries. The company admitted bribing government-employed doctors in Greece for more than a decade to win business.
Richard L. Cassin | Thursday, December 29, 2011 at 1:28PM Here's the current top ten list for corporate defendants.
Thomas Fox | Tuesday, December 20, 2011 at 8:08AM As December is a time for reflection on the past twelve months, I have been considering the FCPA Enforcement Action year.
Richard L. Cassin | Tuesday, November 22, 2011 at 8:51AM The latest issue of the Rx Compliance Report included summaries of our posts, a flock of pharmas and why benchmarking matters.
